7 Leukemia Clinical Trials in Hot Springs, AR (2026)

Q: How do I join a clinical trial in Hot Springs?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Hot Springs research site will contact you.

Recruiting Leukemia Studies in Hot Springs

NCT04267848Recruiting

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by...

Hot Springs, ARPHASE31,210 participantsNational Cancer Institute (NCI)

View Study Details

NCT06095583Recruiting

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

The Study is a Phase 3, randomized, three-arm, double-blind, placebo-controlled, multi-regional clinical research study to evaluate the safety and efficacy use of toripalimab alone or in combination w...

Hot Springs, ARPHASE3756 participantsShanghai Junshi Bioscience Co., Ltd.

View Study Details

NCT06801834Recruiting

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

The goal of this clinical study is to learn more about the study drug sacituzumab govitecan (SG; Trodelvy®; GS-0132; IMMU 132), versus standard of care (SOC) in participants with previously treated ex...

Hot Springs, ARPHASE3695 participantsGilead Sciences

View Study Details

NCT06646276Recruiting

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

The Purpose of the Study is to Compare the Efficacy and Safety of BMS-986489 (Anti-fucosyl-GM1+ Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide to that of Atezolizumab...

Hot Springs, ARPHASE3530 participantsBristol-Myers Squibb

View Study Details

NCT07005128Recruiting

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin and etoposide on prolon...

Hot Springs, ARPHASE3330 participantsAmgen

View Study Details

NCT04269902Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic ...

Hot Springs, ARPHASE3247 participantsNational Cancer Institute (NCI)

View Study Details

NCT04205968Recruiting

Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers

This phase II trial studies how well ramucirumab and paclitaxel or the FOLFIRI regimen (leucovorin calcium, fluorouracil, and irinotecan hydrochloride) work in treating patients with small bowel cance...

Hot Springs, ARPHASE294 participantsSWOG Cancer Research Network

View Study Details

About Leukemia Clinical Trials in Hot Springs

Leukemia is a group of blood cancers that develop in the bone marrow and result in abnormal white blood cells. Types include acute myeloid (AML), acute lymphoblastic (ALL), chronic myeloid (CML), and chronic lymphocytic (CLL). Treatment varies by type and may include chemotherapy, targeted therapy, and stem cell transplant.

There are currently 7 leukemia clinical trials recruiting participants in Hot Springs, AR. These studies are seeking a combined 3,862 participants. Research is being sponsored by National Cancer Institute (NCI), Shanghai Junshi Bioscience Co., Ltd., Gilead Sciences and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Leukemia Clinical Trials in Hot Springs — FAQ

Are there leukemia clinical trials in Hot Springs?

Yes, there are 7 leukemia clinical trials currently recruiting in Hot Springs, AR. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Hot Springs?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Hot Springs research site will contact you about next steps.

Are clinical trials in Hot Springs free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Hot Springs studies also compensate for your time and travel.

What leukemia treatments are being tested?

The 7 active trials in Hot Springs are testing new therapies including novel drugs, biologics, and treatment approaches for leukemia.

Data updated July 22, 2026 from ClinicalTrials.gov